
VRX Market Capitalization Overview
Market Cap: $2.50B as of Nov 4, 2025
$2.50B
Past Month+$2.09B (506.93%)
As of Nov 4, 2025, VRX has a market capitalization of $2.50B. Over the past 30 days, its market cap has increased by 518.79%, while in the last 12 months, it has increased by 405.75%.
Market capitalization represents the total value of Valeant Pharma International as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
VRX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of VRX helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Valeant Pharma International as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
VRX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of VRX helps investors assess the company's size and compare it with competitors for better investment decisions.
VRX Market Cap & Key Trends
See Valeant Pharma International’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in VRX
Order type
Buy in
Order amount
Est. shares
0 shares
VRX Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Nov 3, 2025 | $2.53B | +518.79% |
| Oct 1, 2025 | $407.77M | -13.80% |
| Sep 2, 2025 | $473.05M | +34.59% |
| Aug 1, 2025 | $351.48M | -15.91% |
| Jul 1, 2025 | $417.96M | +51.56% |
| Jun 2, 2025 | $275.77M | -15.46% |
| May 1, 2025 | $326.21M | -14.84% |
| Apr 1, 2025 | $383.04M | -12.83% |
| Mar 3, 2025 | $439.42M | -1.48% |
| Feb 3, 2025 | $445.99M | -8.31% |
| Jan 2, 2025 | $486.43M | +1.53% |
VRX End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2025 | $2.50B | +405.75% |
| 2024 | $493.79M | +1.22% |
| 2023 | $487.85M | +28.88% |
| 2022 | $378.53M | -77.09% |
| 2021 | $1.66B | +34.30% |
| 2020 | $1.24B | — |
FAQs About Valeant Pharma International (VRX) Market Cap
As of Nov 4, 2025, the market capitalization of VRX is $2.50B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Valeant Pharma International’s market capitalization has increased by 506.93%, changing from $411.47M to $2.50B as of Nov 4, 2025.
In the last 3 months, Valeant Pharma International’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Valeant Pharma International’s market capitalization increased from $487.85M in January to $493.79M in December, reflecting a 1.22% change.
In the past five years, VRX has had a compound annual growth rate (CAGR) of -16.69% in market capitalization. This means its market cap has shrunk at an average rate of -16.69% per year.